#BharatBiotech

Dr Harsh Vardhan

drharshvardhan

Disgraceful for anyone to politicise such a critical issue. Sh @ShashiTharoor, Sh @yadavakhilesh & Sh @Jairam_Ramesh don't try to discredit well laid out science-backed protocols followed for approving #COVID19vaccines Wake

Sandeep

dr_dsandeep

Well, @netshrink sir, I'd like to re-emphasize how much disinformation Anoo Bhuyan in her two tweets, screenshots given here. I'll use the same article which you shared, published by @BloombergQuint.

Malini Aisola

malini_aisola

Ella misleads again "12yrs & above we have already done a trial"Facts: There are data for 14 kids in age grp of 12-18 yrs from the Phase 2 trial of

सिद्धार्थ

das_seed

@BharatBiotech's COVAXIN (COVID19 vaccine) trial results in 20 rhesus macaques is out. https://www.bharatbiotech.com/blog/vaccines/covaxin-animal-study-results/ https://www.researchsquare.com/article/rs-65715/v1@malini_aisola @drkamnaka

JayEnAar

GorwayGlobal

I actually have sympathy for @BharatBiotech's scientists and the volunteers who took part in their clinical trials so far. They have been let down by bad science and poor regulatory

Banjot Kaur

Banjotkaur

The fact they are not sharing efficiacy data is making them give such statements. Somani: Till date, 22,500 participants have been vaccinated in ph_3.The vaccine has been found to be

Dr Sumaiya Shaikh

Neurophysik

In the light of various new homologous strains, in addition to the UK one, emerging globally, that may be evolved to escape the neutralising antibodies post vaccinations. It is in

Rajiv Mehta

rajivmehta19

Merck takes distance; you don't want to embark on a possible genocide.Ken Frazier, CEO of the world's leading vaccine producer, the pharmaceutical company Merck & Co., in an interview with

Dr. Haryax Pathak

HaryaxPathak

#COVAXINWould I take COVAXIN if offered to me?Yes.Why? Read on.Disclaimer: This isn't about vaccine nationalism or supporting bad science or my bio . This is purely a PERSONAL choice/approach to

सिद्धार्थ

das_seed

Dr Krishna Ella's (CEO, Bharat Biotech) press brief today. He angrily described how big of blunder "dosing error" in a single-blind AZD1222 (AstraZeneca/Oxford COVID19 vaccine) trial in UK was.Points out

Dr Sumaiya Shaikh

Neurophysik

My analysis of the paper released by #BharatBiotech researchers & the Press Statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of 1out of 3 COVID-19

Dr. Haryax Pathak

HaryaxPathak

#COVID19India - A thread for the Layman.I'll attempt to keep it as simple and concise as possible.A) PrecautionsB) TestingC) VaccinesD) ?? Herd Immunity ??E) MISINFORMATION/MYTHS/CONSPIRACIES 1/n A) PRECAUTIONSThe second

Dr Sumaiya Shaikh

Neurophysik

COVAXIN Efficacy: A thread...n0 Q1: Is there a method to hypothesise the efficacy of COVAXIN when no data has been released?Q2: How is this efficacy enhanced & measured? Q3: Why

Dr. Haryax Pathak

HaryaxPathak

#COVID19vaccines - #IndiaFightsCorona News/Updates - IndiaDifferent Vaccines, Different MechanismsTime-frame and Roll-outWhat To Expect?Got Vaccinated. What now?Adverse Reactions???Countering MisinformationA thread.1/n News/Updates - #India

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.